V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330007799 | 330004625 | null | 70 | Palliative (P) | 2014-02-06 | 2014-02-25 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | Y | 330012730 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330007800 | 330008520 | 1.78 | null | Curative (C) | 2016-09-22 | 2016-09-22 | CARBOPLATIN + RT | 02 | N | 330012733 | CARBOPLATIN + RT |
| 330007801 | 330008520 | 1.78 | 61.7 | Palliative (P) | 2017-06-26 | 2017-07-10 | CarboPEC-Taxol | 02 | N | 330012733 | CARBOPLATIN + PACLITAXEL |
| 330007802 | 330008520 | 1.75 | 15.2 | Curative (C) | 2017-08-07 | 2017-09-19 | BENDAMUSTINE + RITUXIMAB | 02 | N | 330012733 | BENDAMUSTINE + RITUXIMAB |
| 330007803 | 330008520 | 1.65 | 39 | null | 2017-04-19 | 2017-05-09 | Bendamustine+Rituximab(Sub Courses) | 2 | Y | 330012733 | BENDAMUSTINE + RITUXIMAB |
| 330007804 | 330012814 | 1.8 | 52.3 | Palliative (P) | null | 2015-10-24 | ALL UKALL2011 Cap Int Maint C PAsp | N | N | 330012747 | UKALL2011 |
| 330007805 | 330004629 | 1.75 | 58.1 | Curative (C) | 2013-02-26 | 2013-03-10 | CARBOPLATIN + RT | null | null | 330012756 | CARBOPLATIN + RT |
| 330007806 | 330008521 | 1.82 | 82.2 | Disease modification (D) | 2013-09-07 | 2013-09-07 | ALL UKALL2011 Std Int Maint A | 02 | N | 330012763 | UKALL2011 |
| 330007807 | 330004631 | 1.78 | 45 | Palliative (P) | 2015-10-06 | 2015-10-13 | Carboplatin + Paclitaxel (weekly) | 2 | N | 330012774 | CARBOPLATIN + PACLITAXEL |
| 330007808 | 330004632 | 1.83 | 89 | null | 2017-04-06 | 2017-04-07 | CARBOPLATIN + RT | N | N | 330012783 | CARBOPLATIN + RT |
| 330007809 | 330004633 | 1.67 | 74.3 | Not known (9) | null | 2014-10-30 | Paclitaxel (2 or 3 weekly) | N | N | 330012785 | PACLITAXEL |
| 330007810 | 330008523 | 1.7 | 52.5 | Disease modification (D) | 2016-01-15 | 2016-02-23 | VAI (Ifos 3g/m2) | 01 | N | 330012793 | VAI |
| 330007811 | 330008523 | 0 | 73.2 | Adjuvant (A) | 2015-10-07 | 2015-11-26 | CARBOPLATIN + RT | 2 | N | 330012793 | CARBOPLATIN + RT |
| 330007812 | 330004637 | 1.53 | 8.3 | Palliative (P) | null | 2017-09-19 | PACLITAXEL | null | null | 330012800 | PACLITAXEL |
| 330007813 | 330008524 | null | 81.7 | Curative (C) | 2014-08-25 | 2014-10-03 | ALL UKALL2011 Del Int C Recon PAsp | N | Y | 330012800 | UKALL2011 |
| 330007814 | 330004641 | 1.65 | 11.3 | Palliative (P) | null | 2017-08-06 | Carboplatin+Fluorouracil 4 or 5 day | null | null | 330012806 | CARBO + FLUOROURACIL |
| 330007815 | 330004642 | 1.78 | 68.1 | Palliative (P) | 2015-09-21 | 2015-09-24 | EURAMOS TRIAL | 02 | N | 330012807 | EURAMOS TRIAL |
| 330007816 | 330004642 | 1.7 | 91.6 | Palliative (P) | 2018-08-15 | 2018-09-02 | Carboplatin + Paclitaxel (3 weekly) | N | Y | 330012807 | CARBOPLATIN + PACLITAXEL |
| 330007817 | 330004642 | 1.82 | 92 | Disease modification (D) | null | 2015-08-16 | ALL UKALL 2011 HD MtxB (Protocol M) | 02 | N | 330012807 | UKALL2011 |
| 330007818 | 330004644 | 0 | 72 | Curative (C) | 2016-04-19 | 2016-05-25 | ALL UKALL2011 Maintenance B3 | N | N | 330012817 | UKALL2011 |
| 330007819 | 330010618 | 1.74 | 72.4 | Curative (C) | 2017-01-24 | 2017-02-24 | ALL UKALL2011 Aug BFM Cons C PegAsp | N | N | 330012821 | UKALL2011 |
| 330007820 | 330010618 | 1.65 | 12.7 | Palliative (P) | 2013-06-27 | 2013-06-27 | CARBOPLATIN + FLUOROURACIL | N | N | 330012821 | CARBO + FLUOROURACIL |
| 330007821 | 330004646 | 1.72 | 98.5 | Disease modification (D) | 2014-05-19 | 2014-05-31 | CARBOPLATIN + RT | N | N | 330012827 | CARBOPLATIN + RT |
| 330007822 | 330004647 | 1.66 | 88 | Adjuvant (A) | 2015-07-31 | 2015-08-29 | VAI (Ifos 3g/m2) | N | N | 330012829 | VAI |
| 330007823 | 330004647 | 1.7 | 62 | Adjuvant (A) | 2015-09-13 | 2015-09-13 | BENDAMUSTINE + RITUXIMAB | N | N | 330012829 | BENDAMUSTINE + RITUXIMAB |
| 330007824 | 330010619 | 1.59 | 68.7 | Palliative (P) | 2013-03-24 | 2013-03-24 | CARBOPLATIN + ETOPOSIDE | N | N | 330012844 | CARBOPLATIN + ETOPOSIDE |
| 330007825 | 330004648 | null | 12.7 | Palliative (P) | null | 2018-03-08 | Paclitaxel 80mg/m2 day 1 8 15 | Y | null | 330012846 | PACLITAXEL |
| 330007826 | 330004648 | 1.6 | 12.7 | Palliative (P) | 2017-12-20 | 2018-01-29 | Paclitaxel (2 or 3 weekly) | N | Y | 330012846 | PACLITAXEL |
| 330007827 | 330004648 | 1.7 | 63.3 | Palliative (P) | 2016-05-09 | 2016-08-04 | ALL UKALL2011 Del Int A Pt1 (PAsp) | 01 | N | 330012846 | UKALL2011 |
| 330007828 | 330008532 | 1.68 | 54.6 | Palliative (P) | 2017-06-09 | 2017-07-27 | Carboplatin + Etoposide IV 3 day | 02 | N | 330012852 | CARBOPLATIN + ETOPOSIDE |
| 330007829 | 330004650 | 1.7 | 77.7 | Not known (9) | 2017-09-20 | 2017-09-20 | Paclitaxel 7 day | 02 | N | 330012855 | PACLITAXEL |
| 330007830 | 330004651 | 1.84 | 78 | Disease modification (D) | 2015-09-12 | 2015-09-13 | Paclitaxel 7 day | 02 | N | 330012858 | PACLITAXEL |
| 330007831 | 330010622 | 1.6 | 60.1 | Palliative (P) | 2016-05-31 | 2016-09-26 | EURAMOS TRIAL | 02 | N | 330012858 | EURAMOS TRIAL |
| 330007832 | 330004652 | 1.68 | 51 | Palliative (P) | 2013-12-24 | 2014-01-11 | Cetuximab + Radiotherapy Maint | null | null | 330012860 | CETUXIMAB + RT |
| 330007833 | 330004653 | 1.56 | 46.6 | Not known (9) | 2018-03-02 | 2018-03-23 | CARBOPLATIN + PACLITAXEL | 2 | N | 330012862 | CARBOPLATIN + PACLITAXEL |
| 330007834 | 330004654 | 1.7 | 71 | Palliative (P) | 2013-06-04 | 2013-09-24 | Carboplatin+Fluorouracil 4 or 5 day | 02 | N | 330012866 | CARBO + FLUOROURACIL |
| 330007835 | 330004654 | 0 | 45.2 | Palliative (P) | 2015-06-10 | 2015-06-18 | Carboplatin + Etoposide IV 3 day | 02 | N | 330012866 | CARBOPLATIN + ETOPOSIDE |
| 330007836 | 330004655 | 1.63 | 48.5 | Curative (C) | 2013-07-27 | 2013-10-15 | CARBOPLATIN + PACLITAXEL | 02 | N | 330012868 | CARBOPLATIN + PACLITAXEL |
| 330007837 | 330004656 | 1.74 | 59.2 | Palliative (P) | 2014-02-18 | 2014-04-20 | EURAMOS TRIAL | 02 | N | 330012875 | EURAMOS TRIAL |
| 330007838 | 330004657 | 0 | null | Disease modification (D) | 2015-03-13 | 2015-03-14 | VAI (Ifos 3g/m2) | 02 | N | 330012880 | VAI |
| 330007839 | 330004657 | null | null | Not known (9) | 2014-12-12 | 2014-12-12 | CARBOPLATIN + RT | N | N | 330012880 | CARBOPLATIN + RT |
| 330007840 | 330004658 | 1.72 | 77.1 | null | null | 2015-06-26 | CARBOPLATIN + RT | N | N | 330012890 | CARBOPLATIN + RT |
| 330007841 | 330008537 | 1.77 | 74.2 | Palliative (P) | 2017-07-11 | 2018-03-27 | PACLITAXEL | 2 | N | 330012899 | PACLITAXEL |
| 330007842 | 330010625 | 1.66 | 101 | Palliative (P) | 2018-09-13 | 2018-09-16 | CARBOPLATIN + FLUOROURACIL | N | N | 330012900 | CARBO + FLUOROURACIL |
| 330007843 | 330004660 | 1.7 | 58.8 | Curative (C) | 2016-04-27 | 2016-04-28 | Carboplatin + Etoposide iv&po | N | N | 330012901 | CARBOPLATIN + ETOPOSIDE |
| 330007844 | 330004661 | 1.52 | 57 | Palliative (P) | 2014-08-29 | 2014-09-16 | EURAMOS TRIAL | N | Y | 330012903 | EURAMOS TRIAL |
| 330007845 | 330004661 | 1.57 | 19.7 | Curative (C) | 2015-07-27 | 2015-07-31 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330012903 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330007846 | 330004661 | null | 11.3 | Palliative (P) | 2015-01-17 | 2015-03-14 | EURAMOS TRIAL | 02 | null | 330012903 | EURAMOS TRIAL |
| 330007847 | 330004663 | 1.8 | 72.4 | Curative (C) | 2016-03-23 | 2016-03-23 | CARBOPLATIN + RT | 2 | Y | 330012909 | CARBOPLATIN + RT |
| 330007848 | 330004664 | null | 74 | Palliative (P) | 2017-03-16 | 2017-03-24 | CarboPEC-Taxol | N | N | 330012915 | CARBOPLATIN + PACLITAXEL |